Fact CheckerSign in

NCT06875908Recruiting

Reliability and Validity of the Turkish Version of General Sleep Disturbance Scale (GSDS-T) in Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 17 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The GSDS-T was developed by Lee KA to assess difficulty falling asleep, waking up during sleep, sleep quality, and daytime alertnes. The Turkish validity and reliability of the scale have been conducted on stroke patients but not on multiple sclerosis patients. The aim of this study is to investigate the validity and reliability of the Turkish version of general sleep disturbance scale (GSDS-T) in patients with multiple sclerosis

Status (registry)
Recruiting
Study type
Observational
Enrollment
126 (estimated)
First submitted
9 Mar 2025
Start date
15 Apr 2025
Primary completion date
20 Jul 2025
Lead sponsor
Istanbul Medeniyet University
NCT number
NCT06875908

What you commit to

  • Study type: Observational
  • Planned participants: 126
  • From 15 Apr 2025 to the primary completion date, 20 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Those with a known mental illness (major depression, schizophrenia, psychosis, etc.),

Other

  • Those with severe spasticity,
  • Those with vision and hearing problems,
  • Those in an acute relapse phase,
  • Those using dietary supplements,
  • Those using tranquilizers or immunosuppressants.

Who the study is looking for

  • Individuals over the age of 18 who have been diagnosed with Multiple Sclerosis for at least two years,
  • Those with an EDSS score \>2.
  • Those without symptoms of insomnia according to the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) diagnostic criteria
  • Individuals whose native language is Turkish and who have the ability to speak and understand.

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Bağcılar Training and Research Hospital
Coordinator of this site? Confirm its status
BağcılarTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.